Thank you, Mr. Chairman.
You are probably aware of the fact that last Monday we met with officials from various federal departments responsible for carrying out the recommendations. The impression I get is that of a buffet. Some drugs are recommended and others not. On the other hand, some are covered across the board. In other cases, some are and some aren't. From what we've been told it appears that those choices depend on the clientele in question.
Mr. Potter, the assistant deputy minister responsible for first nations and Inuit health, told me, when I asked him about Lantus, a drug for diabetes, that this particular drug was eligible. However, it isn't under other programs.
I would like to ask Mr. Nakagawa about this, because he deals directly with British Columbians.
Do people in your province know that if they were Inuit, if they lived in another province, they might have access to a drug that could improve their health? Or, are they, rather, kept in the dark about these drugs? Why would these drugs be available to some people and not others, for example those in your province?